Cargando…

Synergism of azlocillin, mezlocillin, piperacillin in combination with tobramycin against Klebsiella and Pseudomonas.

Fifty-three clinical isolates of Klebsiella and fifty-one clinical isolates of Pseudomonas aeruginosa, twenty-six of which were carbenicillin-(CARB) resistant, were tested for susceptibility to mezlocillin (MEZ), azlocillin (AZL), and piperacillin (PIP), both alone and in combination with tobramycin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Downs, J. T., Andriole, V. T., Ryan, J. L.
Formato:	Texto
Lenguaje:	English
Publicado:	Yale Journal of Biology and Medicine 1986
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2590060/ https://www.ncbi.nlm.nih.gov/pubmed/3634545

Ejemplares similares

Trimeric Tobramycin/Nebramine Synergizes β-Lactam Antibiotics against Pseudomonas aeruginosa
por: Dhiman, Shiv, et al.
Publicado: (2023)

In Vitro Synergy of Cefamandole-Tobramycin Combinations
por: Valenti, August J., et al.
Publicado: (1977)

Effect of Different Piperacillin-Tazobactam Dosage Regimens on Synergy of the Combination with Tobramycin against Pseudomonas aeruginosa for the Pharmacokinetics of Critically Ill Patients in a Dynamic Infection Model
por: Tait, Jessica R., et al.
Publicado: (2022)

Synergy of Vancomycin with Penicillins and Cephalosporins Against Pseudomonas, Klebsiella, and Serratia
por: Donabedian, Haig, et al.
Publicado: (1977)

Tobramycin-Linked Efflux Pump Inhibitor Conjugates Synergize Fluoroquinolones, Rifampicin and Fosfomycin against Multidrug-Resistant Pseudomonas aeruginosa
por: Yang, Xuan, et al.
Publicado: (2018)

Comment on: Population pharmacokinetics and dosing optimization of mezlocillin in neonates and young infants
por: Standing, Joseph F
Publicado: (2022)

Azlocillin can be the potential drug candidate against drug-tolerant Borrelia burgdorferi sensu stricto JLB31
por: Pothineni, Venkata Raveendra, et al.
Publicado: (2020)

Antibacterial Efficacy of Liposomal Formulations Containing Tobramycin and N-Acetylcysteine against Tobramycin-Resistant Escherichia coli, Klebsiella pneumoniae, and Acinetobacter baumannii
por: Alarfaj, Reem E., et al.
Publicado: (2022)

Development of a High Performance Liquid Chromatographic Assay Measuring Mezlocillin in Serum or Tissue
por: Mya, Sandra, et al.
Publicado: (1993)

Crystal structures of penicillin‐binding protein 3 in complexes with azlocillin and cefoperazone in both acylated and deacylated forms
por: Ren, Jingshan, et al.
Publicado: (2016)

Itaconic Acid Increases the Efficacy of Tobramycin against Pseudomonas aeruginosa Biofilms
por: Ho, Duy-Khiet, et al.
Publicado: (2020)

Combined Treatment of 6-Gingerol Analog and Tobramycin for Inhibiting Pseudomonas aeruginosa Infections
por: Ham, So-Young, et al.
Publicado: (2021)

Anti-bacterial mechanism of baicalin-tobramycin combination on carbapenem-resistant Pseudomonas aeruginosa
por: Jin, Li-Min, et al.
Publicado: (2023)

Evaluation of Tobramycin and Ciprofloxacin as a Synergistic Combination Against Hypermutable Pseudomonas Aeruginosa Strains via Mechanism-Based Modelling
por: Rees, Vanessa E., et al.
Publicado: (2019)

In Vitro Synergy of Levofloxacin Plus Piperacillin/Tazobactam against Pseudomonas aeruginosa
por: Chachanidze, Vladimir, et al.
Publicado: (2009)

Staphylococcus aureus interaction with Pseudomonas aeruginosa biofilm enhances tobramycin resistance
por: Beaudoin, T., et al.
Publicado: (2017)

Combined effect of linolenic acid and tobramycin on Pseudomonas aeruginosa biofilm formation and quorum sensing
por: Chanda, Warren, et al.
Publicado: (2017)

Effect of Bacteriophage Infection in Combination with Tobramycin on the Emergence of Resistance in Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Coulter, Lindsey B., et al.
Publicado: (2014)

Antibacterial activity of iron oxide, iron nitride, and tobramycin conjugated nanoparticles against Pseudomonas aeruginosa biofilms
por: Armijo, Leisha M., et al.
Publicado: (2020)

Free and Nanoencapsulated Tobramycin: Effects on Planktonic and Biofilm Forms of Pseudomonas
por: Sans-Serramitjana, Eulalia, et al.
Publicado: (2017)

RpoN Promotes Pseudomonas aeruginosa Survival in the Presence of Tobramycin
por: Viducic, Darija, et al.
Publicado: (2017)

1414. Inoculum Effect of Piperacillin/Tazobactam Concentration on Emergence of Resistance in Klebsiella aerogenes
por: Custodio, Marco, et al.
Publicado: (2018)

Hydrogels Embedded With Melittin and Tobramycin Are Effective Against Pseudomonas aeruginosa Biofilms in an Animal Wound Model
por: Maiden, Michael M., et al.
Publicado: (2019)

Eradication of Pseudomonas aeruginosa in cystic fibrosis patients with inhalation of dry powder tobramycin
por: Akkerman-Nijland, Anne M., et al.
Publicado: (2020)

Gene Expression Profiling of Pseudomonas aeruginosa Upon Exposure to Colistin and Tobramycin
por: Cianciulli Sesso, Anastasia, et al.
Publicado: (2021)

Exploring Antibiotic-Potentiating Effects of Tobramycin–Deferiprone Conjugates in Pseudomonas aeruginosa
por: Gandhi, Karan, et al.
Publicado: (2023)

Marine-Derived Quorum-Sensing Inhibitory Activities Enhance the Antibacterial Efficacy of Tobramycin against Pseudomonas aeruginosa
por: Busetti, Alessandro, et al.
Publicado: (2014)

Synergistic Activity of Repurposed Peptide Drug Glatiramer Acetate with Tobramycin against Cystic Fibrosis Pseudomonas aeruginosa
por: Murphy, Ronan A., et al.
Publicado: (2022)

2407. Emerging Piperacillin/Tazobactam Resistance in Escherichia coli and Klebsiella sp.
por: Suseno, Mira, et al.
Publicado: (2018)

Rapid Detection of Piperacillin-Tazobactam Resistance in Klebsiella pneumoniae and Escherichia coli
por: Ortiz de la Rosa, José Manuel, et al.
Publicado: (2023)

Bactericidal Effect of Tomatidine-Tobramycin Combination against Methicillin-Resistant Staphylococcus aureus and Pseudomonas aeruginosa Is Enhanced by Interspecific Small-Molecule Interactions
por: Boulanger, Simon, et al.
Publicado: (2015)

The ineffectiveness of tobramycin combination therapy in Streptococcus faecium endocarditis.
por: Goldstein, J. A., et al.
Publicado: (1983)

Liposome-Encapsulated Tobramycin and IDR-1018 Peptide Mediated Biofilm Disruption and Enhanced Antimicrobial Activity against Pseudomonas aeruginosa
por: Alzahrani, Nouf M., et al.
Publicado: (2022)

In Vitro Synergism of Azithromycin Combination with Antibiotics against OXA-48-Producing Klebsiella pneumoniae Clinical Isolates
por: Singkham-in, Uthaibhorn, et al.
Publicado: (2021)

Ease of use of tobramycin inhalation powder compared with nebulized tobramycin and colistimethate sodium: a crossover study in cystic fibrosis patients with pulmonary Pseudomonas aeruginosa infection
por: Greenwood, James, et al.
Publicado: (2017)

Tobramycin reduces key virulence determinants in the proteome of Pseudomonas aeruginosa outer membrane vesicles
por: Koeppen, Katja, et al.
Publicado: (2019)

Tobramycin and Amikacin Delay Adhesion and Microcolony Formation in Pseudomonas aeruginosa Cystic Fibrosis Isolates
por: Olivares, Elodie, et al.
Publicado: (2017)

Tobramycin and bicarbonate synergise to kill planktonic Pseudomonas aeruginosa, but antagonise to promote biofilm survival
por: Kaushik, Karishma S, et al.
Publicado: (2016)

Involvement of Acquired Tobramycin Resistance in the Shift to the Viable but Non-Culturable State in Pseudomonas aeruginosa
por: Mangiaterra, Gianmarco, et al.
Publicado: (2023)

Characterization of Piperacillin/Tazobactam-Resistant Klebsiella oxytoca Recovered from a Nosocomial Outbreak
por: Fujita, Ai, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_mqqrlgmb7kna3mpatgs1o69irf